These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6175810)

  • 21. [Acceleration of amiodarone elimination by cholestyramine].
    Nitsch J; Lüderitz B
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1241-4. PubMed ID: 3743429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of cardiac and plasma drug levels during long-term amiodarone therapy.
    Debbas NM; Du Cailar C; Sassine A; Derancourt J; Demaille JG; Puech P
    Eur J Clin Invest; 1983 Apr; 13(2):123-7. PubMed ID: 6409635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
    Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
    Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(12):1805-10. PubMed ID: 4096733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of phenobarbitone on the pharmacokinetics and tissue levels of amiodarone in the rat.
    Fruncillo RJ; Bernhard R; Swanson BN; Vlasses PH; Ferguson RK
    J Pharm Pharmacol; 1985 Oct; 37(10):729-31. PubMed ID: 2867144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy.
    Marchiset D; Bruno R; Djiane P; Cano JP; Benichou M; Serradimigni A
    Biopharm Drug Dispos; 1985; 6(2):209-15. PubMed ID: 4005397
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of amiodarone on oral digoxin bioavailability in healthy volunteers.
    Maragno I; Santostasi G; Gaion RM; Paleari C
    Int J Clin Pharmacol Res; 1984; 4(2):149-53. PubMed ID: 6469441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and bioavailability of oral ergometrine in male volunteers.
    de Groot AN; Vree TB; Hekster YA; van den Biggelaar-Martea M; van Dongen PW; van Roosmalen J
    Biopharm Drug Dispos; 1994 Jan; 15(1):65-73. PubMed ID: 8161717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
    Escoubet B; Jaillon P; Berger Y; Commin P; Menasché P; Piwnica A; Echter E
    Am Heart J; 1986 Feb; 111(2):280-5. PubMed ID: 3946169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone pharmacokinetics. I. Acute dose-dependent disposition studies in rats.
    Weir SJ; Ueda CT
    J Pharmacokinet Biopharm; 1986 Dec; 14(6):601-13. PubMed ID: 3820092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the clinical pharmacokinetics of amiodarone.
    Paton DM; Webster DR; Neutze JM
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):41-9. PubMed ID: 6371407
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of cefroxadin (CGP 9000) in man.
    Gerardin A; Lecaillon JB; Schoeller JP; Humbert G; Guibert J
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):15-26. PubMed ID: 7069577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kinetics of citalopram: single and multiple dose studies in man.
    Kragh-Sørensen P; Overø KF; Petersen OL; Jensen K; Parnas W
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):53-60. PubMed ID: 6939299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.